RECOMBINANT GANODERMA LUCIDUM IMMUNOMODULATORY PROTEIN (RLZ-8) FOR USE IN TREATING MELANOMA

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP14836534.9

公开号：

EP3023104B1

申请日:

2014.06.13

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

A use of recombinant ganoderma immunoregulatory protein (rLZ-8) in a preparation of a drug for treating melanoma is disclosed. By establishing experimental animal models of orthotopic tumors and metastatic tumors, an anti-tumor effect of the rLZ-8 is researched, which indicates that the rLZ-8 significantly inhibits a growth of the orthotopic tumors of the melanoma and a formation of metastases of the melanoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/